Leisure Acquisition Corp.
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $200M
- Underwriters
- Focus
- Travel, Leisure, Gaming, Recreation
- SEC Filings
- 1716947
- Public Embarc Page
- https://embarc.com/capital/spac/1716947/LACQ/leisure-acquisition
- IPO Ticker
- LACQ
SPAC Leadership
Information on the SPAC leadership.
- Executive ChairmanA. Lorne Weil
- Chief Executive Officer and DirectorDaniel B. Silvers
- Chief Financial Officer, Treasurer and SecretaryGeorge Peng
- Senior Vice President — Finance and Business DevelopmentEric Carrera
- DirectorMarc J. Falcone
- DirectorSteven M. Rittvo
- DirectorDavid L. Weinstein
Target Information
Information on the SPAC target for merger.
- Company
- Ensysce Biosciences
- Presentation
- Investor Presentation (SEC) on 2021-05-18
- Description
- Ensysce is "a clinical-stage drug company that is developing an innovative new class of powerful, tamper-proof prescription medicines that seek to prevent both drug abuse and drug overdoses"and address "the unmet need for safe, abuse-resistant opioids."